Basic Cardiovascular Sciences 2025  /  The Age of Metabolism  /  How Do SGLT2 Inhibitors Reduce Cardiovascular Events and Heart Failure?
Logo

American Heart Association

  81
  0

Final ID:

How Do SGLT2 Inhibitors Reduce Cardiovascular Events and Heart Failure?

  • Arany, Zoltan  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Zoltan Arany: DO NOT have relevant financial relationships
Meeting Info:

Basic Cardiovascular Sciences 2025

2025

Baltimore, Maryland

Session Info:

The Age of Metabolism

Friday, 07/25/2025 , 03:15PM - 04:30PM

General Session

More abstracts on this topic:
Foxm1-Mediated Mitochondrial Function in Cardiomyocytes Protects Cardiac Ischemic Injury Through Suppressing Mkrn1-Dependent LKB1 Ubiquitination

Song Shuai, Zhang Xiaokai, Sun Aijun, Ge Junbo

Glutamine-serine Metabolism Control Pathologic Vascular Stiffness

Chan Stephen

More abstracts from these authors:
Metabolomic Profile of Human End-Stage Ischemic Cardiomyopathy Reveals Few Differences from Non-Ischemic Cardiomyopathy

Tanosaki Sho, Bedi Kenneth, Margulies Kenneth, Arany Zoltan

One Carbon Metabolism Defect In Failing Hearts

Jung Jae Woo, Flam Emily, Bedi Kenneth, Jang Cholsoon, Rabinowitz Joshua, Margulies Kenneth, Arany Zoltan

You have to be authorized to contact abstract author. Please, Login
Not Available